Search

Your search keyword '"Day, John"' showing total 136 results

Search Constraints

Start Over You searched for: Author "Day, John" Remove constraint Author: "Day, John" Publisher wiley Remove constraint Publisher: wiley
136 results on '"Day, John"'

Search Results

3. Atrial cardiomyopathy: from cell to bedside

4. Response to “Delay in AF ablation costs lives”

5. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long‐term outcomes in patients with and without structural heart disease

6. Efficiency and safety of high‐power ablation guided by Lesion size index: an ex vivo porcine heart study

7. Non‐negative matrix factorisation of Raman spectra finds common patterns relating to neuromuscular disease across differing equipment configurations, preclinical models and human tissue

9. Water T2 could predict functional decline in patients with dysferlinopathy

10. Scientific rationale for a higher dose of nusinersen

11. Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study

13. The application of Raman spectroscopy to the diagnosis of mitochondrial muscle disease: A preliminary comparison between fibre optic probe and microscope formats

15. Different trajectories in upper limb and gross motor function in spinal muscular atrophy

16. The influence of chalk grasslands on butterfly phenology and ecology

18. Clinical Variability in Spinal Muscular Atrophy Type III

20. Predicting resilience of ecosystem functioning from co‐varying species' responses to environmental change

21. Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study

22. Journal of Eukaryotic Microbiology / Beyond the 'Code' : a guide to the description and documentation of biodiversity in ciliated protists (Alveolata, Ciliophora)

23. Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination

24. Vagus nerve injury symptoms after catheter ablation for atrial fibrillation

27. Revised upper limb module for spinal muscular atrophy: Development of a new module

28. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

30. WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

31. Beyond the “Code”: A Guide to the Description and Documentation of Biodiversity in Ciliated Protists (Alveolata, Ciliophora)

32. Revised upper limb module for spinal muscular atrophy: Development of a new module

36. Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia

39. Pulmonary Vein Isolation for Atrial Fibrillation in the Postpneumonectomy Population: A Feasibility, Safety, and Outcomes Study

40. Five-Year Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction

41. Initial Independent Outcomes from Focal Impulse and Rotor Modulation Ablation for Atrial Fibrillation: Multicenter FIRM Registry

43. LTBP4genotype predicts age of ambulatory loss in duchenne muscular dystrophy

45. Intracardiac Ultrasound for Esophageal Anatomic Assessment and Localization During Left Atrial Ablation for Atrial Fibrillation

48. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers

50. Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug‐Refractory ICD Shocks

Catalog

Books, media, physical & digital resources